Professor Lydia Tabernero, founder of TaBriX, joined innovators, founders and investors at Venture Cafe Manchester, on 7 May 2026, presenting as part of an event organised by Nucleate.
The session brought together members of Manchester’s growing life sciences and biotech community, providing an opportunity to share the vision behind TaBriX’s work in developing novel therapies for difficult-to-treat infections and to connect with others across the regional innovation ecosystem.Prof Tabernero’s participation reflects TaBriX’s continued engagement with the founders, researchers and organisations helping to shape the future of health innovation in the North West.
